The New York Sun

Pill Forms of Wegovy and Zepbound Are Expected To Increase Weight-Loss Market, but High Costs Are a Concern

The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.
The Manila Times

Best Weight Loss Pills for 2026? FDA Approves First Oral GLP-1 as Patients Evaluate Wegovy, Zepbound, and Telehealth Access Pathways

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound

Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for ...
Flow Space on MSN

Update: FDA approves oral version of Wegovy, first GLP-1 pill approved specifically for weight management

Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...
AOL

Zepbound vs. Wegovy: Comparing weight loss drugs

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss

Eli Lilly reports Phase 3 data showing oral obesity drug orforglipron maintained weight loss after Wegovy or Zepbound, beating placebo.
Becker's Hospital Review

Wegovy, Zepbound more than fairly priced: Report

Wegovy and Zepbound, two popular weight loss GLP-1 medications, would remain cost-effective at a higher price, according to an Oct. 29 revised report from the Institute for Clinical and Economic ...